Jointly sponsored by the Fudan University Shanghai Medical College and the Shanghai Key Laboratory of organ transplantation, the 2024 Asian Organ Transplantation Symposium (TSS) , hosted by Sun Yat-sen Hospital of Fudan University, will be 2024 in Shanghai, China, from November 22 to 24. The experts of organ transplantation and related disciplines from home and abroad will be invited to give lectures and discuss on the hot and difficult issues in the field of organ transplantation. We would like to introduce to you the members of the Chinese section of the Congress Committee:
General Assembly President
Zhu Tongyu, chief physician, professor, professor, The National Committee of the Chinese People’s Political Consultative Conference. He is currently vice president of the Fudan University Shanghai Medical College, Director of the Shanghai Institute of Bacteriophage and drug resistance, director of the Shanghai Key Laboratory of organ transplantation, and director of the Shanghai Kidney Transplantation quality control center, director of Fudan University and Research Institute. Shanghai Leading Talents, Shanghai outstanding academic leaders, Shanghai Health System New 100 plan, China Hospital Association 2020 Outstanding Hospital President. He is also the chairman of organ transplantation branch of Shanghai Medical Association and the standing member of organ transplantation branch of Chinese Medical Doctor Association. Deputy editor-in-chief of AmJTransplant (Chinese edition) , standing editorial board member of Organ Transplant, editorial board member of Int J Clin Pract, Chinese Journal of Organ Transplant, reviewer of New Engl J Med, Am J Transplant, etc. . He has long been engaged in clinical and basic research work in kidney transplantation, phage therapy for drug-resistant bacterial infections, BK virus activation mechanism and prevention and treatment strategies, and pathogen diagnosis and treatment. Responsible for presiding over more than fifteen national science and technology major projects, National Natural Science Foundation of China and other scientific research projects. In recent years, special attention has been paid to the prevention and control of infections after transplantation. Since 2018, he has hosted the first domestic clinical trial of phage therapy for super-resistant bacterial infections. He has published nearly 100 SCI papers in Emerg Microbes Infect, J Infect, eclinical medicine, Embo J, Med and other journals, and applied for 11 patents, 5 of which have been granted.
China member of the Convention Committee
Zhang Xiaodong, M. D. , enjoys the special allowance of the State Council
Current positions: Professor of Beijing Chao-yang Hospital Urology, chief physician, professor.
Part-time academic Red Cross Society of China: Member of the Expert Committee on organ donation, member of the kidney Transplantation group of the organ Transplantation branch of the Chinese Medical Association, member of the Standing Committee of the organ Transplantation branch of the Chinese Medical Association, member of the Standing Committee of the Urology Branch of the Beijing Medical Association, Chairman of the Urology Committee of the Chaoyang District Society for Preventive Medicine, member of the editorial board of Transplant Proceedings () , member of the editorial board of the Chinese Journal of Transplantation, and executive member of The Transplantation Scientific Symposium (TSS) , involved in the preparation of monographs, co-edited“CS Huang Surgery”, “Wu steping urology”. Editor-in-chief clinical kidney transplantation, clinical medicine for kidney transplantation. “Urodynamics”, “Smith’s urology”, “Oncological surgery”. Award-winning situation, China Medical Science and Technology First Prize (ranked second) , Beijing Medical Science and Technology Third Prize (ranked first) . Scientific Research Fund, 2 National Natural Science Foundation projects, 1 key project of“Sailing Plan” of Beijing Municipality.
Wan Jun, Chair Professor, Department of Surgery, the University of Hong Kong, director of the clinical and translational laboratory, the laboratory of liver transplantation and liver cancer, the laboratory of Organ Transplantation and regeneration, the University of Hong Kong, director, Central Laboratory, Shenzhen Hospital, University of Hong Kong
President, Hong Kong Association for Science and Technology (Since 2018) President, Hong Kong Society for Immunology (Since 2023) president, international society for Liver Transplantation (2018-2019) Transplantation: Deputy Editor (Since 2015) Annals of Surgery: Editorial Board -LRB-Since 2018)
Clinical, translational, and basic research in liver transplantation injury, hepatocellular carcinoma, and tumor recurrence after liver transplantation. The research results are at the international leading level in related fields, and more than 200 papers have been published in many internationally renowned journals, his recent achievements in innovation and transformation have won the gold award at the 2024 Geneva Invention Fair and the special award of the China Invention Association.
Fu yingxin, director of Kidney Transplantation Department of Shenzhen No. 3 People’s Hospital, head of Organ Transplantation Research Institute
American Johns Hopkins University has completed postdoctoral and South University of Science and Technology of China Professor
More than 1000 cases of kidney transplantation and 80 cases of Pancreas-kidney transplantation have been performed in our hospital for more than 20 years.
Member of pancreas and small bowel transplantation group, ninth committee of Organ Transplantation Society, Chinese Medical Association
Standing Committee member, Transplantation Technology Branch, China Medical Biotechnology Association
Standing Committee member, Kidney Transplantation Branch, China Society for promotion of international exchange in medical care
Member of Transplant Medicine Committee of Chinese Research Hospital Association
International Society for pancreas and islet transplantation.
Chinese Journal of organ transplantation, organ transplantation and other organ transplantation professional journal editorial board scientific research achievements: presided over the national natural science foundation of 2,2 Tianjin Health and Family Planning Commission projects; He has edited 1 follow-up guideline for organ transplantation, 1 clinical guideline for Simultaneous Pancreas-kidney transplantation, and published more than 50 SCI and Chinese core papers.
Pang Li, National Sun Yat-sen University Assistant Researcher, Sun Yat-sen Memorial Hospital, Liver Transplant Center & Department of Biliary and pancreatic surgery
International Association for Liver Transplantation (ILTS) BASIC & Translational Research Committee
International Association for Liver Transplantation Working Group on accelerated rehabilitation surgery (ERAS) youth committee
Member, Organ Medicine and Technology Society of Guangdong Province
Member of Immunological Society of Hong Kong (HKSI)
Member of International Transplant Society (TTS)
Member of the International Association for Liver Transplantation (ILTS)
Member of the Hong Kong Association of scientific researchers (HKSA)
Immunological mechanism of recurrence of hepatocellular carcinoma after liver transplantation.
He graduated from the Department of Surgery of the University of Hong Kong in 2021, and has been awarded“Rising Star Award” and“Vanguard Basic Science Award” by the International Association of Liver Transplantation (ILTS) . He presided over a naturalist from the National Cancer Research Foundation and two special grants from the national postdoctoral program, six SCI papers were published in Cancer Letters and 38 in Annals of Surgery, Nano Research and Transplantation as co-authors.
Liu Jiang, Research Assistant Professor, Department of Surgery, University of Hong Kong. He is engaged in clinical, basic and translational research in hepatobiliary and pancreatic surgery and liver transplantation, focusing on immune and metabolic mechanisms and medical applications of biomaterials. A total of 34 SCI papers were published, with a total of 622 citations and an H-index of 14. International guidelines for biomarkers of accelerated recovery after liver transplantation and consensus for diagnosis of small liver syndrome in living donor liver transplantation. In 2022, mild graft steatosis was found to be a risk factor for long-term poor prognosis after living donor liver transplantation. The first preclinical study of stem cell therapy for liver cancer based on micro-robot was carried out. A theory of regional immune microenvironment for hepatocellular carcinoma recurrence after liver transplantation was proposed. He is a member of the Youth Committee of the International Society for Liver Transplantation, the scientific committee of the International Registry of Living Donor Liver Transplantation, the working group of the World Hilar cholangiocarcinoma guidelines, and the Youth Committee of the Hong Kong Association of scientists. He has been the recipient of several international academic awards, including the International Society for Liver Transplantation Outstanding Young Researcher Award, the International Society for Transplantation student-mentor award, and the International Digestive Disease Forum Young Researcher Award, and the Gold Award of Geneva International Invention Fair and the Special Commendation Award of China Invention Association.
Secretary and Contact Person of the conference
Yang Cheng
Doctor, associate chief physician, Master Tutor, h-index 26
Member of the Ninth Youth Group and Transplantation Foundation Group, organ transplantation branch, Chinese Medical Association
Member, Immunotherapy Engineering Branch, Chinese Biomedical Engineering Society
Vice Biomedical Engineering, Transplant Immunology Committee, Immunotherapy Engineering Branch, Chinese Academy of Medical Sciences
Committee member, Transplantation Technology Branch, China Medical Biological Association
Member of the Youth Committee of Organ Transplantation Branch of Shanghai Medical Association
He is currently a member of the editorial board of Frontiers in Cell and Developmental Biology (IF: 6.081) , a young member of the editorial board of the Chinese Journal of Organ Transplantation, and a former member of the editorial board of the Journal of Translational Medicine (IF: 8.44)
Shanghai Science and Technology Youth start-up program
Shanghai top-notch young talents development program
The new excellent youth program of Shanghai Health System
Fudan University Excellence 2025 programme, China Organ Transplantation Development Foundation elite programme
The 4th grand ceremony of famous doctors of china-young talents
Shanghai Ubo has won 7 Young Scientist Award/Basic Science Award from American Transplant Society, International Transplant Society and European Transplant Society
The first/corresponding author has published 63 SCI papers with a cumulative IF > 320 and a total of more than 2000 citations
Dissertations of the Ministry of Education, the National Nature Fund evaluation experts
微信扫一扫
关注该公众号